The Use of Mole Mapping Diagrams to Increase Skin Self Examination Accuracy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to improve Skin Self-Examination accuracy by a simple cost effective intervention requiring participants to complete a mole-mapping diagram.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Melanoma

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Skin Self Examination Mole Mapping Diagram Melanoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Blinding Strategy

SINGLE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mole Mapping Diagram

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male and female subjects above age 18 of any ethnicity will be enrolled in this study.

Exclusion Criteria

* Subjects will be excluded from the study if they have significant skin disease which would not allow manipulation of their photographs consistent with the rest of the subjects.
* Since the study instructions are in English, Non-English speakers will be excluded.
* Those with co-morbidity sufficiently severe to prevent them from being able to perform a SSE will be excluded.
* In addition, those with cognitive impairment who are unable to give informed consent, or to understand the study instructions given to them, will be excluded.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Martin A Weinstock, MD, Ph.D

Role: PRINCIPAL_INVESTIGATOR

Veterans Affairs Medical Center Providence, RI

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

00001402

Identifier Type: -

Identifier Source: org_study_id